Symbols

PSTV

Plus Therapeutics·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 2

Consensus Rating "Strong Buy"

High Gross Profit Margin

EPS Below Expectations

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PSTV

Plus Therapeutics, Inc.

A U.S. pharmaceutical company that develops innovative, targeted radiotherapeutics for cancers

Industry

Biological Technology

Established Date

Listing Date

12/19/2005

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.plustherapeutics.com

Security Type

Common stock

Office address

6420 Levit Green Boulevard, Suite 310, Houston, TX

Business

Introduction

Plus Therapeutics, Inc., was originally incorporated as a California general partnership in July 1996 and was incorporated in Delaware in May 1997. The Company is an American healthcare company focused on the development and commercialization of precise diagnosis and targeted radiopharmaceuticals for central nervous system (" CNS ") cancers. CNSide Diagnostics, LLC, its wholly-owned subsidiary, develops and commercializes proprietary laboratory-developed tests, such as CNSide, designed to identify tumor cells that have metastasized to the central nervous system in cancer and melanoma patients.

Company Financials

EPS

PSTV has released its 2025 Q4 earnings. EPS was reported at 0.92, versus the expected -0.03, beating expectations. The chart below visualizes how PSTV has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

PSTV has released its 2025 Q4 earnings report, with revenue of 1.37M, reflecting a YoY change of -3.19%, and net profit of -5.71M, showing a YoY change of -46.37%. The Sankey diagram below clearly presents PSTV's revenue sources and cost distribution.